Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000812295-07-000075
Filing Date
2007-02-14
Accepted
2007-02-14 13:01:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 13G 12/31/06 AMLN amln2102007.txt SC 13G 6839
  Complete submission text file 0000812295-07-000075.txt   9087
Mailing Address 151 DETROIT ST. DENVER CO 80206-4805
Business Address 151 DETROIT ST. DENVER CO 80206-4805 3033333863
JANUS CAPITAL MANAGEMENT LLC (Filed by) CIK: 0000812295 (see all company filings)

EIN.: 753019302 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 0000

Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Subject) CIK: 0000881464 (see all company filings)

EIN.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-42168 | Film No.: 07617161
SIC: 2834 Pharmaceutical Preparations